|
| |
DR. ADRIANO CAVALCANTI
The PhysOrg article
Virtual 3D nanorobots could lead to real cancer-fighting
technology said
Adriano Cavalcanti,
Bijan Shirinzadeh,
Robert Freitas, Jr., and
Tad Hogg, representing institutions in Melbourne, Australia, and
the U.S.,
have published their simulation procedure in a recent issue of
Nanotechnology. Just as 3D simulations previously helped engineers
greatly accelerate developmental research in the semiconductor
industry, Cavalcanti and colleagues hope that virtual nanorobots,
virtual biomolecules and virtual arteries will accelerate the progress
of nanorobot development.
"The software NCD (nanorobot control design) is a system implemented to
serve as a test bed for nanorobot 3D prototyping," Cavalcanti, CEO of
the Center for Automation in Nanobiotech and researcher at Monash
University in Melbourne, told PhysOrg.com. "It is an advanced
nanomechatronics simulator that provides physical and numerical
information for nanorobot task-based modeling. Serving as a fast
development platform for medical nanorobots investigation, the NCD
simulations show how to interact and control a nanorobot inside the
body."
"One of the major factors for successfully developing nanorobots is to
bring together professionals with interdisciplinary views of science
and technologies," Cavalcanti said. "It is necessary to keep your eyes
open for chemistry, materials engineering, electronics, computing,
physics, mechanics, photonics, pharmaceutics, and medicine
technologies. Our work is advancing progressively because we have
experts from different backgrounds participating. We all pursue a
common interest in working together to build medical nanorobots."
Adriano Cavalcanti, Ph.D.
is Chairman and CEO of
CAN Center for Automation in Nanobiotech.
Its key development areas are biosensor, nanobioelectronics, and
nanorobotics
for in vivo nanomedicine application in diabetes, cancer, cardiology,
and brain aneurysm. It is focused
on the implementation of new technologies for innovative integrated
system
design. The equipment prototyping at CAN should enable new
instrumentation for in vivo diagnosis, drug delivery and surgery. Their
business project is to provide new effective medical devices through
the development of commercial nanobiotechnology.
Adriano coauthored
Hardware Architecture for Nanorobot Application in Cancer
Therapy,
Nanorobots for Laparoscopic Cancer Surgery,
Medical Nanorobot Architecture Based on Nanobioelectronics,
CMOS-based Nanorobot to Combat Cancer,
Nanorobot Communication Techniques: A Comprehensive
Tutorial,
Hardware Architecture for Nanorobot Application in Cerebral
Aneurysm,
Nanorobot for Treatment of Patients with Artery Occlusion,
Computational Nanomechatronics: A Pathway for Control and
Manufacturing
Nanorobots, and
Nanorobotics Control Design: A Practical Approach Tutorial.
Read the
full list of his publications!
He has been developing several
research projects related to autonomous systems, equipment prototyping,
and physically based simulation. Among other projects, he is
working through the publication of two new books in Nanorobotics, and
is
preparing to commercialize the software Nanorobot Control Design (NCD)
as a valuable tool for Nanotechnologists, Engineers, and Machine
Designers.
Adriano earned a B.S. in Computer Science from Sao Paulo State
University, a M.S. in Electrical Engineering focusing on automation and
control from State University of Campinas, Brazil, and a Ph.D. in
Mechanical Engineering from Monash University, Australia.
Read
Adriano Cavalcanti on Medical Nanorobotics Feasibility,
Nanorobot for drug delivery and diagnosis,
Medical nanorobotics for diabetes,
Nanorobot pioneer reveals status of simulator, stem cell
work,
Nanorobots to improve health care, and
Nanorobot Hardware Architecture for Medical Defense.
Print bio!
|
|
